| __timestamp | Merck & Co., Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 11606000000 | 675200000 |
| Thursday, January 1, 2015 | 10313000000 | 771800000 |
| Friday, January 1, 2016 | 9762000000 | 1205500000 |
| Sunday, January 1, 2017 | 9830000000 | 1146500000 |
| Monday, January 1, 2018 | 10102000000 | 1125800000 |
| Tuesday, January 1, 2019 | 10615000000 | 1166100000 |
| Wednesday, January 1, 2020 | 8955000000 | 1175500000 |
| Friday, January 1, 2021 | 9634000000 | 1111400000 |
| Saturday, January 1, 2022 | 10042000000 | 1210100000 |
| Sunday, January 1, 2023 | 10504000000 | 1274600000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, understanding the financial strategies of leading companies is crucial. Over the past decade, Merck & Co., Inc. and Perrigo Company plc have showcased distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Merck's SG&A expenses fluctuated, peaking in 2014 and 2019, with a notable dip in 2020. This reflects a strategic shift, possibly due to market conditions or internal restructuring. In contrast, Perrigo's SG&A expenses have steadily increased, rising by approximately 89% from 2014 to 2023. This consistent growth suggests a focus on expansion and market penetration. These trends highlight the contrasting approaches of these pharmaceutical giants in managing operational costs, offering valuable insights for investors and industry analysts alike.
Operational Costs Compared: SG&A Analysis of Eli Lilly and Company and Merck & Co., Inc.
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Novartis AG
Merck & Co., Inc. vs Regeneron Pharmaceuticals, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Merck & Co., Inc. vs Merus N.V. Trends and Insights
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Merck & Co., Inc. vs Evotec SE Trends and Insights
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Perrigo Company plc
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Comparing SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Perrigo Company plc Trends and Insights
Breaking Down SG&A Expenses: Perrigo Company plc vs Xenon Pharmaceuticals Inc.
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Vericel Corporation
Cost Management Insights: SG&A Expenses for Perrigo Company plc and Mesoblast Limited